Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Biotherapy
Published in: Biotherapy 4/1998

01-12-1998

EIevated serum level of Thioredoxin in patients with Hepatocellular Carcinoma

Authors: Kunihisa Miyazaki, Noriko Noda, Shuichi Okada, Yoshiaki Hagiwara, Michio Miyata, Ikunosuke Sakurabayashi, Naohito Yamaguchi, Takashi Sugimura, Masaaki Terada, Hiro Wakasugi

Published in: Biotherapy | Issue 4/1998

Login to get access
Metadata
Title
EIevated serum level of Thioredoxin in patients with Hepatocellular Carcinoma
Authors
Kunihisa Miyazaki
Noriko Noda
Shuichi Okada
Yoshiaki Hagiwara
Michio Miyata
Ikunosuke Sakurabayashi
Naohito Yamaguchi
Takashi Sugimura
Masaaki Terada
Hiro Wakasugi
Publication date
01-12-1998
Publisher
Kluwer Academic Publishers
Published in
Biotherapy / Issue 4/1998
Print ISSN: 0921-299X
Electronic ISSN: 1573-8280
DOI
https://doi.org/10.1023/A:1008032703468

Other articles of this Issue 4/1998

Biotherapy 4/1998 Go to the issue

OriginalPaper

Low dose Oral Interferon Alpha 2a in HIV-1 Seropositive Patients: A Double-blind, Placebo-controlled Trial

OriginalPaper

Cytokine effect on ex vivo expansion of haemopoietic stem cells from different human sources

OriginalPaper

Antitumor effect of a peptide-glucan preparation extracted from Agaricus blazei in a double-grafted tumor system in mice

OriginalPaper

Analysis of effector cells in tumor-bearing mice pre-treated with active specific immunization followed by cyclophosphamide

OriginalPaper

Effect of herbal therapy on herpes labialis and herpes genitalis

OriginalPaper

Contribution of cytokines on the suppression of lung metastasis
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Watch now

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine
Image Credits